\
&
Contact us
\
&
Contact us
Published on | 3 weeks ago
Programmes HealthThe Innovative Health Initiative (IHI) has published the draft text of topics under consideration for inclusion in the next call for proposals on the Future Opportunities page of the website. Currently, the draft topics are under consultation and it is therefore likely that the topics may change between now and the call launch, and applicants should check the final, approved topic texts once the calls are launched.
Herewith the draft text of what is under consideration for inclusion in IHI call 11, which is a two-stage call scheduled for launch in Q2 2025:
More information is available on the IHI website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Culture and society Security Digital, Industry & Space
The open and forthcoming calls under Horizon Europe have been published on the Funding & Tenders Portal (Funding - Call for proposals) However, there are technical issues with the filter functions in Pillar 2: filtering per cluster does not display all 2025 call topics within this cluster and advertise call topics of other work programmes. The... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
